{"id":"W2745246284","doi":"10.1161/jaha.117.005639","title":"Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Alirocumab; Medicine; Apolipoprotein B; Internal medicine; Ezetimibe; Statin; PCSK9; Evolocumab; Placebo; Endocrinology; Cholesterol; Lipoprotein; Gastroenterology; Apolipoprotein A1; LDL receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00949205,0.001783204,0.006278021,0.0007837991,0.0002949675,0.00179721,0.0005809194,0.001073718,0.001327521],"category_scores_gemma":[0.008809235,0.0006806627,0.01095292,0.001278,0.0005574511,0.000874414,0.0008790503,0.001293429,0.0001587626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007280869,"about_ca_system_score_gemma":0.001208775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001116676,"about_ca_topic_score_gemma":0.003622145,"domain_scores_codex":[0.9954962,0.002689261,0.0007140553,0.000483805,0.0004001795,0.0002165644],"domain_scores_gemma":[0.9946532,0.002640336,0.001622025,0.000448972,0.0003527167,0.000282599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.592937,0.0006624499,0.01368535,0.01829585,0.3102091,0.0001282446,0.0001900673,0.001992029,0.003022581,0.000130429,0.002038634,0.05670828],"study_design_scores_gemma":[0.3568206,0.02836238,0.08524296,0.002169186,0.517827,0.0003410781,0.000151922,0.001993423,0.001501302,0.0007270749,0.004711499,0.000151543],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6546754,0.3351665,0.002054769,0.0006822774,0.0004548195,0.001694846,0.002976232,0.0001803577,0.002114891],"genre_scores_gemma":[0.9463475,0.04673276,0.001828548,0.0008500248,0.0003762634,0.001348935,0.001914141,0.00005363844,0.0005481459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00949205,"threshold_uncertainty_score":0.05019939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01774328189761847,"score_gpt":0.3017636663371935,"score_spread":0.284020384439575,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}